Japan OKs Sanofi's inactivated polio vaccine
Japan has granted marketing approval for its first inactivated polio vaccine (IPV), Sanofi's Imovax Polio, and will begin using the vaccine in public immunization programs beginning Sept. 1.
NEWS FROM FIERCEPHARMACheap generic stops bleeding effectively but gets little useBy Eric Palmer
TOP HEADLINES
FEATURED STORY
'Designer' lymph nodes could boost cancer vaccines
Researchers at the Moffitt Cancer Center are developing "designer" lymph nodes that could be used to boost the effects of cancer vaccines.
MMR and autism: Italy's courts get involved
An Italian health news website seems to have reported that an Italian court has ruled that an MMR vaccine caused autism in a child.
First 'cross-kingdom' vax effective in PhI
NovaDigm Therapeutics is developing a vaccine that could work against both bacteria and fungi, and could even combat resistant bacteria such as MRSA. The company presented Phase I results at the 15th Annual Conference on Vaccine Research.
Study: Further insight into Merck HIV vax infection increase
A recent study published in the Journal of Infectious Disease confirmed that a vaccine study halted in 2007 showed an increased risk of infection in the first 18 months for subgroups of the men who were vaccinated, but that this difference disappeared after 18 months.
Pneumococcal vax cuts deaths, but cases tripled
While vaccines against Streptococcus pneumoniae have cut the number of deaths from this bug that can cause pneumonia and meningitis, the number of cases has tripled in the past 50 years.
Swine flu vax could offer universal flu protection
Researchers in Canada are touting a 2009 swine flu shot as a potential route to a universal vaccine that could target all forms of influenza, according to data published in Frontiers of Immunology.
From Our Sister Sites
Knode has sprung to life with web-based software to enable life sciences stakeholders to hunt for top experts.
The deal comes amid rapid business expansion at Decision Resources, which provides web-based research tools, predictive analytics and other services to drugmakers and other healthcare stakeholders.
POPULAR COMMENT THREADS